Research is our number 1 priority
The outstanding traceability of our samples, categorised according to strictly defined clinical characteristics of patients in the cohorts and studies, makes it possible to do research on patient sub-groups perfectly characterised throughout different stages of the disease.
The great amount of samples with associated information on the clinical characteristics of patients which is available allows scientists to conduct statistically and scientifically meaningful research.
The quality of the samples allows for the study of cellular, molecular and “omic” questions.
The HIV HGM BioBank provides samples to research projects which have been approved by the Clinical Research Ethics Committee (CEIC) of the institution where the study is to take place, and which have been evaluated and considered adequate by this BioBank’s Scientific and Ethics Committees.